HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruth E Hogg Selected Research

Complement C3a (Complement 3a)

1/2016Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: Complement activation in AMD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruth E Hogg Research Topics

Disease

13Macular Degeneration (Age-Related Maculopathy)
11/2023 - 11/2008
4Glaucoma
01/2020 - 01/2016
3Diabetic Retinopathy (Retinopathy, Diabetic)
11/2023 - 08/2013
3Diabetes Mellitus
01/2023 - 08/2013
2Atrophy
11/2023 - 01/2017
2Epiretinal Membrane (Epiretinal Membranes)
01/2020 - 01/2018
2Inflammation (Inflammations)
11/2019 - 07/2012
2Fibrosis (Cirrhosis)
01/2017 - 01/2016
1Acquired Immunodeficiency Syndrome (AIDS)
09/2023
1Low Vision (Subnormal Vision)
09/2023
1Dry Eye Syndromes (Dry Eye Syndrome)
07/2023
1Retinal Detachment (Retinal Detachments)
01/2023
1Chronic Renal Insufficiency
01/2020
1Retinal Perforations
01/2020
1Chronic Disease (Chronic Diseases)
11/2019
1Macular Edema
01/2018
1Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2017
1Eye Diseases (Eye Disease)
02/2016
1Blindness (Hysterical Blindness)
01/2016
1Polypoidal Choroidal Vasculopathy
01/2016
1Geographic Atrophy
11/2008
1Hypertension (High Blood Pressure)
06/2008
1Choroidal Neovascularization
06/2008
1Cardiovascular Diseases (Cardiovascular Disease)
06/2008

Drug/Important Bio-Agent (IBA)

11Retinaldehyde (Retinal)IBA
11/2023 - 01/2016
3Biomarkers (Surrogate Marker)IBA
11/2019 - 01/2016
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2017 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 01/2016
2AntioxidantsIBA
08/2013 - 11/2008
1TabletsIBA
09/2023
1Triglycerides (Triacylglycerol)IBA
01/2023
1SDDSIBA
12/2022
1GATIBA
01/2020
1Serum Amyloid A Protein (Serum Amyloid A)IBA
11/2019
1LipidsIBA
11/2019
1HDL LipoproteinsIBA
11/2019
1Proteins (Proteins, Gene)FDA Link
11/2019
1polyterephthalic acid anhydrideIBA
09/2019
1Interleukin-8 (Interleukin 8)IBA
01/2017
1C-Reactive ProteinIBA
01/2017
1CytokinesIBA
01/2017
1ChemokinesIBA
01/2017
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2017
1ORALIT (ORS)IBA
01/2016
1Complement C3a (Complement 3a)IBA
01/2016
1Free RadicalsIBA
08/2013
1Complement Factor H (Factor H)IBA
10/2012
1LuteinIBA
07/2012
1ZeaxanthinsIBA
07/2012
1Macular PigmentIBA
07/2012
1Complement Factor B (Factor B)IBA
02/2009
1Complement C2 (Complement Component 2)IBA
02/2009
1Carotenoids (Carotene)IBA
11/2008
1CholesterolIBA
06/2008

Therapy/Procedure

2Mediterranean Diet
01/2019 - 01/2017
2Therapeutics
01/2017 - 01/2016
1Refractive Surgical Procedures
07/2023
1Laser In Situ Keratomileusis (LASIK)
07/2023
1Traction
01/2020
1Diet Therapy (Therapy, Diet)
01/2019